AXIM Axim Biotechnologies, Inc.
Fundamentals / CIK 0001514946 / USDAxim Biotechnologies, Inc. reported $93K in revenue and a net loss of $4.14M for the trailing twelve months ended June 30, 2024 (up 76.0% year over year), with a -2493.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AXIM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$93K +76.0% YoY
-
Operating Income TTM-$2.32M -2493.4% margin
-
Net Income TTM-$4.14M -4452.1% net margin
-
Diluted EPS TTM-$0.04 Split-adjusted
-
Free Cash Flow TTM-$1.03M -1109.3% FCF margin
-
Cash & ST Investments Jun 30, 2024-- Total debt: $94K
Annual revenue and net income
10 fiscal years (2012 to 2023), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40K | $8.9K | $60K | $196K | $48K | $47K | $49K | $0 | $22K | $43K |
| Cost of Revenue | -- | -- | -- | $8.5K | $43K | $154K | $50K | $0 | -- | -- |
| Gross Profit | -- | -- | -- | $187K | $4.7K | -$107K | -$1.2K | $0 | -- | -- |
| Research & Development | $125K | $154K | $285K | $2.06M | $1.35M | $236K | $571K | $0 | -- | -- |
| Selling, General & Admin | $2.24M | $4.08M | $5.67M | -- | -- | $3.41M | $9.48M | $506K | -- | -- |
| Total Operating Expenses | $2.79M | $4.66M | $14.04M | $5.22M | $3.15M | $3.65M | $10.05M | $506K | $63K | $58K |
| Operating Income | -$2.75M | -$4.65M | -$13.97M | -$5.04M | -$3.15M | -$3.76M | -$10.05M | -$506K | -- | -- |
| EBITDA | -$2.32M | -$4.23M | -$11.86M | -$5.02M | -$3.15M | -$3.76M | -$10.05M | -$506K | -- | -- |
| Interest Income | $0 | $257 | -- | $0 | $1.6K | $0 | -- | -- | -- | -- |
| Interest Expense | $140K | $262K | $140K | $456K | $315K | $276K | $43K | $33K | -- | -- |
| Income Before Tax | -$8.06M | -$6.24M | -$16.02M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$538K | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- |
| Net Income | -$8.06M | -$6.24M | -$16.03M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$583K | -$89K | -$15K |
| Basic EPS | -$0.04 | -$0.04 | $0.12 | -$0.12 | -$0.08 | -$0.17 | -$0.27 | -$0.02 | $0.00 | -- |
| Diluted EPS | -$0.04 | -$0.04 | $0.12 | -$0.12 | -$0.08 | -$0.17 | -$0.27 | -$0.02 | $0.00 | -- |
| Basic Shares Outstanding | -- | -- | -- | 57.3M | 53.3M | 41.7M | 37.1M | 33.0M | 33.0M | 33.0M |
| Diluted Shares Outstanding | -- | -- | -- | 57.3M | 53.3M | 41.7M | 37.1M | 33.0M | 33.0M | 33.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17K | $53K | $13K | $9.6K | $9.9K | $7.4K | $7.6K | $1.3K |
| Cost of Revenue | $1.7K | -- | -- | -- | $0 | -- | -- | -- |
| Gross Profit | $16K | -- | -- | -- | $9.9K | -- | -- | -- |
| Research & Development | $4.1K | $15K | $36K | $35K | $34K | $20K | $45K | $30K |
| Selling, General & Admin | $473K | $334K | $624K | $457K | $567K | $591K | $998K | $1.18M |
| Total Operating Expenses | $585K | $457K | $767K | $598K | $708K | $718K | $1.15M | $1.32M |
| Operating Income | -$569K | -$404K | -$754K | -$589K | -$698K | -$711K | -$1.14M | -$1.32M |
| EBITDA | -$461K | -$296K | -$647K | -$482K | -$591K | -$604K | -$1.04M | -$1.21M |
| Interest Income | -- | -- | $0 | $0 | -- | $0 | $1 | $0 |
| Interest Expense | $178K | $164K | $105K | $65K | $752K | $58K | $157K | $57K |
| Income Before Tax | -$2.27M | -$292K | -$1.90M | $328K | -$3.72M | -$2.76M | -$899K | -$2.03M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2.27M | -$292K | -$1.90M | $328K | -$3.72M | -$2.76M | -$899K | -$2.03M |
| Basic EPS | -$0.01 | -$0.00 | -- | $0.00 | -$0.02 | -$0.01 | -- | -$0.01 |
| Diluted EPS | -$0.01 | -$0.00 | -- | $0.00 | -$0.02 | -$0.01 | -- | -$0.01 |
| Basic Shares Outstanding | -- | -- | -- | 232.4M | 226.3M | -- | -- | 171.9M |
| Diluted Shares Outstanding | -- | -- | -- | 478.5M | 226.3M | -- | -- | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | $47K | $453K | $1.81M | $2.06M | $713K | $134K | $661K | $127 | $19K |
| Cash & Short-Term Investments | -- | $47K | $453K | $1.81M | $2.06M | $713K | $134K | $661K | $127 | $19K |
| Accounts Receivable, Net | $0 | $0 | $0 | $0 | -- | -- | -- | -- | -- | $20K |
| Inventory | -- | -- | $20K | $9.8K | $8.8K | $38K | $201K | $0 | -- | -- |
| Other Current Assets | -- | $14K | $20K | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $156K | $104K | $637K | $2.02M | $2.11M | $1.37M | $1.18M | $738K | $3.1K | $39K |
| Property, Plant & Equipment, Net | $134K | $94K | $117K | $5.6K | $8.9K | $12K | $16K | $0 | -- | -- |
| Intangible Assets | -- | $3.99M | -- | $54K | $63K | $63K | -- | -- | $54K | $94K |
| Total Non-Current Assets | $3.97M | $4.11M | $4.69M | $61K | $71K | $63K | $79K | $0 | $54K | $94K |
| Total Assets | $4.12M | $4.21M | $5.32M | $2.09M | $2.19M | $1.45M | $1.26M | $738K | $57K | $133K |
| Short-Term Debt | -- | -- | -- | $412K | $5.0K | $5.0K | -- | -- | -- | -- |
| Deferred Revenue (Current) | $303K | $333K | -- | -- | -- | -- | -- | -- | -- | $22K |
| Other Current Liabilities | $0 | $27K | $33K | $23K | $23K | $23K | -- | -- | -- | -- |
| Total Current Liabilities | $5.98M | $3.39M | $2.58M | $3.32M | $7.71M | $3.02M | $2.55M | $1.32M | $151K | $138K |
| Long-Term Debt | $137K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $5.80M | $5.64M | $5.08M | $4.85M | $772K | $804K | $411K | $0 | $0 | $0 |
| Total Liabilities | $11.78M | $9.04M | $7.66M | $8.17M | $8.48M | $3.82M | $2.96M | $1.32M | $151K | $138K |
| Total Debt (incl. Leases) | $137K | $20K | -- | $412K | $5.0K | $5.0K | -- | -- | -- | -- |
| Common Stock | $25K | $19K | $14K | $6.0K | $5.5K | $5.3K | $4.0K | $3.3K | $3.3K | $3.3K |
| Retained Earnings | -$72.18M | -$64.13M | -$57.88M | -$28.99M | -$22.24M | -$18.07M | -$10.78M | -$692K | -- | -$20K |
| Total Stockholders' Equity | -$7.66M | -$4.83M | -$2.34M | -- | -- | -$2.37M | -$1.70M | -$581K | -$94K | -$4.7K |
| Total Equity | -$7.66M | -$4.83M | -$2.34M | -$6.08M | -$6.28M | -$2.37M | -$1.70M | -$581K | -$94K | -$4.7K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | -- | -- | $23K | $97K | $54K | $47K | $65K |
| Cash & Short-Term Investments | -- | -- | -- | $23K | $97K | $54K | $47K | $65K |
| Accounts Receivable, Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $20K |
| Other Current Assets | -- | -- | -- | -- | -- | $3.0K | $14K | -- |
| Total Current Assets | $20K | $97K | $156K | $23K | $97K | $57K | $104K | $173K |
| Property, Plant & Equipment, Net | $118K | $128K | $134K | $69K | $78K | $86K | $94K | $107K |
| Intangible Assets | -- | -- | -- | $3.69M | $3.79M | -- | $3.99M | -- |
| Total Non-Current Assets | $3.71M | $3.84M | $3.97M | $4.02M | $4.15M | $3.99M | $4.11M | $4.35M |
| Total Assets | $3.73M | $3.93M | $4.12M | $4.04M | $4.25M | $4.04M | $4.21M | $4.52M |
| Deferred Revenue (Current) | $233K | $250K | $303K | $311K | $318K | -- | $333K | -- |
| Other Current Liabilities | -- | -- | $0 | $0 | -- | $0 | $27K | -- |
| Total Current Liabilities | $6.57M | $4.80M | $5.98M | $4.28M | $8.37M | $4.86M | $3.39M | $2.71M |
| Long-Term Debt | $94K | $118K | $137K | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $6.69M | $6.58M | $5.80M | $5.72M | $5.63M | $5.34M | $5.64M | $5.54M |
| Total Liabilities | $13.26M | $11.38M | $11.78M | $10.00M | $14.00M | $10.20M | $9.04M | $8.25M |
| Total Debt (incl. Leases) | $94K | $118K | $137K | $254K | $276K | -- | $20K | $49K |
| Common Stock | $29K | $28K | $25K | $24K | $23K | $22K | $19K | $16K |
| Retained Earnings | -$74.75M | -$72.48M | -$72.18M | -$70.28M | -$70.61M | -$66.89M | -$64.13M | -$61.19M |
| Total Stockholders' Equity | -$9.53M | -$7.45M | -$7.66M | -$5.96M | -$9.75M | -$6.16M | -$4.83M | -$3.73M |
| Total Equity | -$9.53M | -$7.45M | -$7.66M | -$5.96M | -$9.75M | -$6.16M | -$4.83M | -$3.73M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$8.06M | -$6.24M | $16.03M | -$6.75M | -$4.17M | -$5.81M | -$10.09M | -$583K | -$89K | -$15K |
| Depreciation & Amortization | $427K | $426K | $2.12M | $13K | $3.4K | $3.4K | $1.1K | $0 | -- | -- |
| Stock-Based Compensation | $198K | $1.11M | $1.14M | $911K | $56K | $1.45M | $5.98M | $0 | -- | -- |
| Change in Receivables | -- | -$20K | -- | -- | -- | -- | -- | -- | $9.0K | $45K |
| Change in Inventory | -- | $20K | -$20K | -$1.0K | $30K | $153K | -$46K | $0 | -- | -- |
| Operating Cash Flow | -$1.03M | -$2.04M | -$2.49M | -$4.85M | -$3.08M | -$1.29M | -$1.54M | -$339K | -$33K | $21K |
| Capital Expenditure | $0 | -$8.7K | -$40K | -- | -- | $0 | $17K | $0 | -- | -- |
| Free Cash Flow | -$1.03M | -$2.05M | -$2.53M | -- | -- | -$1.29M | -$1.52M | -$339K | -- | -- |
| Investing Cash Flow | $0 | -$8.7K | -$50K | -- | $0 | $0 | -$17K | $0 | -- | -$100K |
| Common Stock Issued | -- | $0 | $359K | -- | -- | $0 | $20K | -- | -- | -- |
| Financing Cash Flow | $1.14M | $1.65M | $2.53M | $4.59M | $4.43M | $1.87M | $1.03M | $1.00M | $14K | $75K |
| Net Change in Cash | $109K | -$406K | -$4.2K | -$252K | $1.34M | $579K | -$527K | $661K | -$19K | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.27M | -$292K | -$1.90M | $328K | -$3.72M | -$2.76M | -$899K | -$2.03M |
| Depreciation & Amortization | $108K | $108K | $107K | $107K | $107K | $107K | $107K | $107K |
| Stock-Based Compensation | $9.6K | $9.6K | $34K | $38K | $21K | $104K | $219K | $517K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -$20K | $1.7K |
| Operating Cash Flow | $553K | -$1.07M | $20K | -$265K | -$644K | -$142K | -$316K | -$321K |
| Capital Expenditure | -- | -$2.8K | -- | -- | -- | -- | -- | -- |
| Free Cash Flow | -- | -$1.07M | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | $0 | -$2.8K | $0 | $0 | $0 | $0 | $0 | -$2.7K |
| Financing Cash Flow | -$644K | $1.01M | $114K | $190K | $688K | $148K | $199K | $423K |
| Net Change in Cash | -$91K | -$60K | $133K | -$74K | $44K | $6.3K | -$116K | $99K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 95.6% | 9.9% | -227.5% | -2.5% | -- | -- | -- |
| Operating Margin | -6961.0% | -52425.6% | -23114.5% | -2574.5% | -6619.5% | -7988.8% | -20451.3% | -- | -- | -- |
| Net Profit Margin | -20395.0% | -70343.1% | -26517.2% | -3453.0% | -8761.7% | -12346.0% | -20539.2% | -- | -411.8% | -34.4% |
| Return on Assets (ROA) | -195.5% | -148.2% | -301.2% | -323.3% | -190.1% | -400.9% | -800.0% | -78.9% | -157.0% | -11.2% |
| Current Ratio | 0.03x | 0.03x | 0.25x | 0.61x | 0.27x | 0.46x | 0.46x | 0.56x | 0.02x | 0.28x |
| Quick Ratio | -- | 0.01x | 0.24x | 0.61x | 0.27x | 0.44x | 0.39x | 0.56x | 0.00x | 0.28x |
| Revenue Growth (YoY) | +345.3% | -85.3% | -- | +311.2% | +1.1% | -4.2% | -- | -100.0% | -50.0% | +333.3% |
| Gross Profit Growth (YoY) | -- | -- | -- | +3867.4% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -133.3% | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -256.4% | +422.7% |
| 5Y Revenue / Share Growth | -- | -- | -- | +420.1% | -32.0% | +162.5% | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2493.4% | -2864.2% | -6917.6% | -9107.8% | -14765.3% | -26000.6% | -52429.7% | -182235.4% |
| Net Profit Margin | -4452.1% | -6548.9% | -20267.8% | -20472.6% | -35951.0% | -42520.1% | -70343.1% | -218733.8% |
| Return on Assets (ROA) | -110.9% | -142.1% | -195.5% | -174.5% | -221.8% | -171.1% | -148.2% | -- |
| Current Ratio | 0.00x | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.03x | -- |
| Quick Ratio | -- | -- | -- | 0.01x | 0.01x | 0.01x | 0.01x | -- |
| Revenue Growth (YoY) | +76.0% | +616.2% | +70.1% | +629.1% | -- | -- | +57.2% | -83.8% |
| Gross Profit Growth (YoY) | +58.5% | -- | -- | -- | -- | -- | -- | -- |